Evidence map›Paper›PMID 32354138›Full record

ArticleNanomaterials (Basel, Switzerland)2020

rAAV-Mediated Overexpression of SOX9 and TGF-β via Carbon Dot-Guided Vector Delivery Enhances the Biological Activities in Human Bone Marrow-Derived Mesenchymal Stromal Cells.

Weikun Meng, Ana Rey-Rico, Mickaël Claudel, Gertrud Schmitt, Susanne Speicher-Mentges, Françoise Pons, Luc Lebeau, Jagadeesh K Venkatesan, Magali Cucchiarini

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Effects of rAAV-Mediated Overexpression ofJournal of tissue engineering and regenerative medicine · 2023
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Advances in Nanomaterials in Biomedicine.Nanomaterials (Basel, Switzerland) · 2021
    Article
  12. Genetics in Cartilage Lesions: Basic Science and Therapy Approaches.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Weikun MengCenter of Experimental Orthopaedics, Saarland University Medical Center, D-66421 Homburg, Germany.
Ana Rey-RicoCell Therapy and Regenerative Medicine Unit, Centro de Investigacións Científicas Avanzadas (CICA), Universidade da Coruña, ES-15071 A Coruña, Spain.ORCID 0000-0003-1682-498X
Mickaël ClaudelLaboratoire de Conception et Application de Molécules Bioactives, Faculty of Pharmacy, UMR 7199 CNRS-University of Strasbourg, F-67401 Illkirch, France.
Gertrud SchmittCenter of Experimental Orthopaedics, Saarland University Medical Center, D-66421 Homburg, Germany.
Susanne Speicher-MentgesCenter of Experimental Orthopaedics, Saarland University Medical Center, D-66421 Homburg, Germany.
Françoise PonsLaboratoire de Conception et Application de Molécules Bioactives, Faculty of Pharmacy, UMR 7199 CNRS-University of Strasbourg, F-67401 Illkirch, France.
Luc LebeauLaboratoire de Conception et Application de Molécules Bioactives, Faculty of Pharmacy, UMR 7199 CNRS-University of Strasbourg, F-67401 Illkirch, France.ORCID 0000-0002-3276-6727
Jagadeesh K VenkatesanCenter of Experimental Orthopaedics, Saarland University Medical Center, D-66421 Homburg, Germany.
Magali CucchiariniCenter of Experimental Orthopaedics, Saarland University Medical Center, D-66421 Homburg, Germany.ORCID 0000-0003-0323-8922
Saarland University · DECentre National de la Recherche Scientifique · FRUniversidade da Coruña · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scaffold-assisted gene therapy is a highly promising tool to treat articular cartilage lesions upon direct delivery of chondrogenic candidate sequences. The goal of this study was to examine the feasibility and benefits of providing highly chondroreparative agents, the cartilage-specific sex-determining region Y-type high-mobility group 9 (SOX9) transcription factor or the transforming growth factor beta (TGF-β), to human bone marrow-derived mesenchymal stromal cells (hMSCs) via clinically adapted, independent recombinant adeno-associated virus (rAAV) vectors formulated with carbon dots (CDs), a novel class of carbon-dominated nanomaterials. Effective complexation and release of a reporter rAAV-

Indexed as

bone marrow-derived mesenchymal stromal cellscarbon dotscartilage repairrAAV vectorsSOX9TGF-β

Identifiers

PMID32354138
PMCPMC7712756
OpenAlexW3021262174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.